Retraction
Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma
Paper Information
Record ID:
60727
Author(s):
Journal:
Publication Date:
May 18, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations2
Post-Retraction(50.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
269
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials
Qichuan Deng, Yü Huang, Jing Zeng et al. (8 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2024
6 citations
6 citations
269 days after retraction
The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer
Luca Grisetti, Clarissa Joy C. Garcia, Anna Alessia Saponaro et al. (5 authors)
Cell Proliferation
Open Access
Published: Apr 2024
10 citations
10 citations
131 days after retraction
Retracted: Network Pharmacology‐Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma
Computational Intelligence and Neuroscience
Computational Intelligence and Neuroscience
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025